[The influence of ursodeoxycholic acid on hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan in chronic liver diseases].
Hayakawa
T
T
Katagiri
K
K
Shiraka
S
S
Nakai
T
T
Takeshima
A
A
Kawamura
Y
Y
Ohnishi
H
H
Hoshino
M
M
Tsukada
K
K
Miyani
M
M
D000328:Adult; D001659:Biliary Tract / Q000000981:diagnostic imaging*; D002908:Chronic Disease; D003840:Deoxycholic Acid / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D008099:Liver / Q000000981:diagnostic imaging*; D008107:Liver Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D015609:Organotechnetium Compounds; D011730:Pyridoxal / Q000031:analogs & derivatives*; D011877:Radionuclide Imaging; D014364:Tryptophan / Q000031:analogs & derivatives*; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
D009942:Organometallic Compounds; D015609:Organotechnetium Compounds; C038081:technetium Tc 99m pyridoxyl-5-methyltryptophan; D003840:Deoxycholic Acid; D011730:Pyridoxal; D014580:Ursodeoxycholic Acid; D014364:Tryptophan